| 2.6 -0.15 (-5.45%) | 05-08 10:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.5 | 1-year : | 4.09 |
| Resists | First : | 3 | Second : | 3.5 |
| Pivot price | 2.33  |
|||
| Supports | First : | 2.02 |
Second : | 1.42 |
| MAs | MA(5) : | 2.65 |
MA(20) : | 2.28 |
| MA(100) : | 2.49 |
MA(250) : | 7.13 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 80.1 |
D(3) : | 83.8 |
| RSI | RSI(14): 58.9 |
|||
| 52-week | High : | 21.4 | Low : | 1.27 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CUTR ] has closed below upper band by 28.7%. Bollinger Bands are 12.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3 - 3.02 | 3.02 - 3.03 |
| Low: | 2.52 - 2.53 | 2.53 - 2.54 |
| Close: | 2.73 - 2.75 | 2.75 - 2.77 |
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
Wed, 08 May 2024
Cutera (CUTR) Set to Announce Quarterly Earnings on Thursday - Defense World
Tue, 07 May 2024
Cutera (CUTR) Beats Q3 Earnings and Revenue Estimates - Yahoo Canada Shine On
Sat, 04 May 2024
Federated Hermes Inc. Has $524000 Position in Cutera, Inc. (NASDAQ:CUTR) - Defense World
Fri, 22 Mar 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ... - Benzinga
Fri, 22 Mar 2024
Cutera, Inc. (NASDAQ:CUTR) Q4 2023 Earnings Call Transcript - Yahoo Finance
Thu, 21 Mar 2024
Cutera, Inc. (CUTR) Q4 2023 Earnings Call Transcript - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 20 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 4.8 (%) |
| Held by Institutions | 89.9 (%) |
| Shares Short | 8,020 (K) |
| Shares Short P.Month | 7,650 (K) |
| EPS | -7.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -8.02 |
| Profit Margin | -71.1 % |
| Operating Margin | -89.5 % |
| Return on Assets (ttm) | -20.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -26.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 10.63 |
| EBITDA (p.s.) | -6.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -138 (M) |
| Levered Free Cash Flow | -114 (M) |
| PE Ratio | -0.34 |
| PEG Ratio | -0.1 |
| Price to Book value | -0.33 |
| Price to Sales | 0.24 |
| Price to Cash Flow | -0.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|